Moreover, a meta-analysis of gene expression profiling in ALS consistently confirmed that the differential expressions of cathepsins B and D, GFAP, and SERPINA3 are significant in both the mouse model and patients with ALS [204]. The gene discussed is SERPINA3; the disease is amyotrophic lateral sclerosis.